The Daily Papule

J DermatolCase report

Venetoclax-Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)

Implications for Diagnosis and Treatment Continuation.

Tanaka N, Iso A, Higashime A

Journal of DermatologyIn the feed 4 Aug 2026, published online 3 Aug 2026, issue 2026 Sep, added to PubMed 4 Aug 2026

Topics: Drug reactionsCancer drugs

Abstract

Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) is an uncommon type of cutaneous drug eruption, most frequently associated with antibiotics such as amoxicillin. Reports of SDRIFE induced by anticancer agents remain limited. We describe a case of SDRIFE in a 77-year-old man treated with venetoclax for acute myeloid leukemia. The eruption developed shortly after drug initiation and resolved rapidly following drug withdrawal without systemic involvement. Notably, venetoclax was continued for a certain period after onset without progression of symptoms. This case highlights the importance of recognizing SDRIFE in patients receiving chemotherapy and suggests that continuation of the causative agent may be feasible in selected cases.

Abstract from PubMed

PMID 42548096 · DOI 10.1111/1346-8138.70445

Comments